Oncology Drugs Export of Lesotho: The Trade Analysis of 2024

Lesotho, based in Southern Africa, with its thriving medical essentials production, has emerged as a top exporter of oncology drugs in the global trade market. Lesotho Import Data says, the growth rate of the oncology market on a regional and global basis, driven by the emergence of the medicinal industry and the increasing prevalence of cancer cases, has been pivotal for the export of oncology drugs from the region. Oncology drugs are the medications used for treating cancer and other immune system-related issues; it’s purposely used for chemotherapy, immunotherapy, and other procedures. Oncology drugs are used to shrink the tumors while preventing the spread of cancer, and they are also used to reduce the symptoms within a few hours of consumption.

The growing aging population of Lesotho and the rise in the exposure of the population to fatal diseases like cancer and other malignant tumors have led to a steady growth rate in the oncology drug export. The deficiency in the production range is recording a slight decline in the trade deficit. The development of the regulatory medical cannabis export industry and the rise in the incidence of cancer cases have resulted in an export trade value of 2 billion US dollars in 2024. Subscribe to Import Globals, an Import Export Trade Provider, to stay updated with the latest information on the oncology drugs export of Lesotho via the Lesotho Trade Data.

POLICY REFORMS SUPPORTING THE EXPORT OF ONCOLOGY DRUGS FROM LESOTHO IN 2024

The Coordinated Border Management Strategy by the Ministry of Trade and Industry has bolstered the predictability of cross-border trade. It has eventually eliminated the strategy streamlining the customs procedures while enhancing the efficiency of trade at borders. The launch of the e-customs tariff platform has improved the transparency in the import and export regulations of oncology drugs. It has cut down the administrative friction while allowing smoother export planning and logistics.

The national single window for trade has centralized the export documentation. It has reduced the processing times while simplifying the compliance and lowering the costs of trade. The regional value chain Lesotho project has shifted the focus of the government authorities to agro-processing and light manufacturing. It has provided support to medium and small enterprises via several export rules and certifications to expand their global reach.

THE LEADING VARIANTS OF ONCOLOGY DRUGS EXPORTED FROM LESOTHO IN 2024

Oncology drugs have become a globally demanded essential due to the increasing use in medical facilities. The tragic shift of the export authorities of Lesotho over this specific category trade has reported diversification for the proper fulfillment of the global demands. According to Lesotho Export Data, the top 10 leading variants of oncology drugs exported from the nation in 2024 are,

  • Pembrolizumab — The total valuation of Pembrolizumab exported from Lesotho in 2024–324 million US dollars
  • Nivolumab — The total valuation of Nivolumab exported from Lesotho in 2024–278 million US dollars
  • Trastuzumab — The total valuation of Trastuzumab exported from Lesotho in 2024–225 million US dollars
  • Bevacizumab — The total valuation of Bevacizumab exported from Lesotho in 2024–219 million US dollars
  • Imatinib — The total valuation of Imatinib exported from Lesotho in 2024–187 million US dollars
  • Rituximab — The total valuation of Rituximab exported from Lesotho in 2024–165 million US dollars
  • Tamoxifen — The total valuation of Tamoxifen exported from Lesotho in 2024–142 million US dollars
  • Docetaxel — The total valuation of Docetaxel exported from Lesotho in 2024–127 million US dollars
  • Cyclophosphamide — The total valuation of Cyclophosphamide exported from Lesotho in 2024–98 million US dollars
  • Capecitabine — The total valuation of Capecitabine exported from Lesotho in 2024–87 million US dollars

TOP 10 EXPORT TRADE PARTNERS OF LESOTHO IN 2024

The country has been focusing on valuable trade with the topmost importers worldwide to record a positive upward trajectory in its oncology drugs export revenue rate. As per the Lesotho Customs Data, the top 10 export trade partners of the nation for oncology drugs in 2024 are,

  • South Africa — The annual valuation of oncology drugs exported from Lesotho to South Africa in 2024–387 million US dollars

Top 5 variants of oncology drugs exported

· Abiraterone

· Acalabrutinib

· Afatinib

· Alectinib

· Alemtuzumab

  • United States — The annual valuation of oncology drugs exported from Lesotho to the United States in 2024–265 million US dollars

Top 5 variants of oncology drugs exported

· Alpelisib

· Altretamine

· Amsacrine

· Anastrozole

· Apalutamide

  • Namibia — The annual valuation of oncology drugs exported from Lesotho to Namibia in 2024–224 million US dollars

Top 5 variants of oncology drugs exported

· Arsenic trioxide

· Asparaginase

· Atezolizumab

· Avelumab

· Axitinib

  • India — The annual valuation of oncology drugs exported from Lesotho to India in 2024–187 million US dollars

Top 5 variants of oncology drugs exported

· Azacitidine

· Bendamustine

· Belantamabmafodotin

· Belzutifan

· Bevacizumab

  • Taiwan — The annual valuation of oncology drugs exported from Lesotho to Taiwan in 2024–167 million US dollars

Top 5 variants of oncology drugs exported

· Binimetinib

· Bortezomib

· Bosutinib

· Brentuximab vedotin

· Brigatinib

  • Tanzania — The annual valuation of oncology drugs exported from Lesotho to Tanzania in 2024–154 million US dollars

Top 5 variants of oncology drugs exported

· Busulfan

· Cabazitaxel

· Cabozantinib

· Capecitabine

· Carfilzomib

  • Eswatini— The annual valuation of oncology drugs exported from Lesotho to Eswatini in 2024–139 million US dollars

Top 5 variants of oncology drugs exported

· Carmustine

· Ceritinib

· Chlorambucil

· Cisplatin

· Cladribine

  • Mexico — The annual valuation of oncology drugs exported from Lesotho to Mexico in 2024–128 million US dollars

Top 5 variants of oncology drugs exported

· Clofarabine

· Copanlisib

· Crizotinib

· Cyclophosphamide

· Cytarabine

  • China — The annual valuation of oncology drugs exported from Lesotho to China in 2024–108 million US dollars

Top 5 variants of oncology drugs exported

· Dabrafenib

· Dactinomycin

· Daratumumab

· Daunorubicin

· Decitabine

  • Germany — The annual valuation of oncology drugs exported from Lesotho to Germany in 2024–102 million US dollars

Top 5 variants of oncology drugs exported

· Docetaxel

· Doxorubicin

· Durvalumab

· Enasidenib

  • Enzalutamide

Comments

Popular posts from this blog

Overview of the Optical Equipment Import of Vietnam in 2023

Seafood Export of Uganda in 2023

Import and Export Procedures in Vietnam 2023